This is consistent with a recent analysis of bulk RNA seq data from prostate cancer biopsies that found an increase in PDL2 transcripts compared with normal tissue, and that higher PDL2 expression was associated with worse outcomes (Zhao et al., 2019). This evidence concerns the gene PDCD1LG2 and Familial prostate cancer.